Related references
Note: Only part of the references are listed.Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer
Kie Kyon Huang et al.
CANCER CELL (2018)
The Hippo pathway as a drug target in gastric cancer
Yiting Qiao et al.
CANCER LETTERS (2018)
Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway
Nianshuang Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Inhibition of Translesion DNA Synthesis as a Novel Therapeutic Strategy to Treat Brain Cancer
Jung-Suk Choi et al.
CANCER RESEARCH (2018)
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
Wantae Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
Sofia M. E. Weiler et al.
GASTROENTEROLOGY (2017)
Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation
Changmin Peng et al.
MOLECULAR CELL (2017)
The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis
Xiao Zhang et al.
NATURE COMMUNICATIONS (2017)
The Hippo pathway in organ development, homeostasis, and regeneration
Vivian Fu et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway
Chao Wang et al.
CANCER RESEARCH (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
The Hippo pathway in intestinal regeneration and disease
Audrey W. Hong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Galectin-Binding O-Glycosylations as Regulators of Malignancy
Charles J. Dimitroff
CANCER RESEARCH (2015)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma
Patrick Tan et al.
GASTROENTEROLOGY (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression
Julien Fitamant et al.
CELL REPORTS (2015)
Complications in advanced or recurrent gastric cancer patients with peritoneal metastasis during and after palliative systemic chemotherapy
Yasuo Hamamoto
MOLECULAR AND CLINICAL ONCOLOGY (2015)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
Pi3kcb Links Hippo-YAP and PI3K-AKT Signaling Pathways to Promote Cardiomyocyte Proliferation and Survival
Zhiqiang Lin et al.
CIRCULATION RESEARCH (2015)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice
Junyan Tao et al.
GASTROENTEROLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Overexpression of YAP1 is Correlated with Progression, Metastasis and Poor Prognosis in Patients with Gastric Carcinoma
Xiaobin Hu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma
Darjus Felix Tschaharganeh et al.
GASTROENTEROLOGY (2013)
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Joseph Rosenbluh et al.
CELL (2012)
Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
Wei Kang et al.
CLINICAL CANCER RESEARCH (2011)
Deep congenic analysis identifies many strong, context-dependent QTLs, one of which, Slc35b4, regulates obesity and glucose homeostasis
Soha N. Yazbek et al.
GENOME RESEARCH (2011)
Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin
Haiying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein
Bin Zhao et al.
CANCER RESEARCH (2009)
Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway
Jianmin Zhang et al.
CANCER RESEARCH (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
The human solute carrier gene SLC35B4 encodes a bifunctional nucleotide sugar transporter with specificity for UDP-xylose and UDP-N-acetylglucosamine
A Ashikov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm
A Vassilev et al.
GENES & DEVELOPMENT (2001)
Share Paper
